Clarus Therapeutics Appoints John Gargiulo Chief Operating Officer
3/17/2014 8:52:40 AM
NORTHBROOK, Ill., March 17, 2014 (GLOBE NEWSWIRE) -- Clarus Therapeutics, Inc., a men's health specialty pharmaceutical company focused on the development and commercialization of REXTORO, an oral testosterone (T) replacement product, today announced that John P. Gargiulo has joined the Company as Chief Operating Officer.
Help employers find you! Check out all the jobs and post your resume.
comments powered by